Comparison of Virtual and In-Person Tobacco Treatment Specialist Training
Date
2023-11-03
Journal Title
Journal ISSN
Volume Title
Citation Stats
Attention Stats
Abstract
Purpose: There is limited research comparing virtual and in-person tobacco treatment specialist (TTS) training. As a result of COVID-19, the Duke-UNC (University of North Carolina) Tobacco Treatment Specialist Training Program (Duke-UNC TTS) transitioned from an in-person to a virtual format, allowing for a comparison of these two training formats. Methods: We conducted an observational study comparing Duke-UNC TTS attendance and evaluations at three courses provided in person in 2019 with the same three courses provided virtually in 2020. Results: The transition from in-person to virtual format was associated with more than a doubling of course attendance. The in-person format enrolled 112 participants; the virtual format enrolled 232 participants, p < 0.05. The virtual format was associated with more than two times the proportion of out-of-state participant attendance. The in-person format enrolled 22.3% out-of-state attendees; the virtual format enrolled 52.8% out-of-state attendees, p < 0.05. Course evaluations showed similar quality scores for measuring perceived knowledge acquisition and course satisfaction. Conclusions: The virtual TTS training format had higher attendance and wider geographical reach without significantly losing quality than the in-person training format. Accordingly, TTS training programs should consider the continued delivery of training through interactive virtual formats to increase accessibility for participants.
Type
Department
Description
Provenance
Subjects
Citation
Permalink
Published Version (Please cite this version)
Publication Info
Davis, J, S Clark, J Greyber, J Dirkes, S Herndon, J Swetlick, S Trout, F Manshaii, et al. (2023). Comparison of Virtual and In-Person Tobacco Treatment Specialist Training. Telehealth and Medicine Today, 8(5). 10.30953/thmt.v8.432 Retrieved from https://hdl.handle.net/10161/34777.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
Collections
Scholars@Duke
James Davis
Dr. James Davis is a practicing physician of Internal Medicine, and serves as the Medical Director for Duke Center for Smoking Cessation, Director of the Duke Smoking Cessation Program and Co-Director of the Duke-UNC Tobacco Treatment Specialist Credentialing Program. His research focuses on development of new pharmaceutical treatments for smoking cessation. He is principal investigator on several trials including a study on “adaptive” smoking cessation and several trials on new medications for smoking cessation. The new medications leverage more novel neurobiological mechanisms - NMDA receptor antagonism, nicotinic receptor antagonism, which impact addiction-based learning and cue response. Additionally, Dr. Davis serves as co-investigator on trials on lung cancer screening, e-cigarettes, minor nicotine alkaloids, imaging trials, lung function trials and others. Dr. Davis leads the Duke Smoke-Free Policy Initiative, is co-author on a national tobacco dependence treatment guideline, and provides training in tobacco dependence treatment for the Duke School of Medicine, Duke Internal Medicine, Family Practice and Psychiatry residency programs.
Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.